Geron to Present at Upcoming Investor Conferences in November
Wednesday, November 7, 2018 - 4:30pm

MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at the following investor conferences:

  • Stifel 2018 Healthcare Conference in New York at 2:00 p.m. ET on Wednesday, November 14, 2018
  • 30th Annual Piper Jaffray Healthcare Conference in New York at 11:30 a.m. ET on Tuesday, November 27, 2018

A live audio webcast of each presentation will be available on Geron’s website, If you are unable to listen to the live presentations, an archived webcast of each presentation will be available on the Company’s website for 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit


Suzanne Messere
Investor and Media Relations

CG Capital

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.